Functional characterization of peptide transporters in MDCKII-MDR1 cell line as a model for oral absorption studies

被引:19
作者
Agarwal, Sheetal [1 ]
Jain, Ritesh [1 ]
Pal, Dhananjay [1 ]
Mitra, Ashim K. [1 ]
机构
[1] Univ Missouri, Sch Pharm, Div Pharmaceut Sci, Kansas City, MO 64110 USA
关键词
Madin-Darby canine kidney cells; MDCKII-MDRI; MDCKII-WT; caco-2; cells; peptide transporter; P-glycoprotein (P-gp); Gly-Sar; apical (AP); basolateral (BL); uptake; transport; permeability;
D O I
10.1016/j.ijpharm.2006.09.056
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
MDCKII-MDR1 cell line has been extensively selected as a model to study P-gp-mediated drug efflux. Recently, investigators have employed this cell line for studying influx of peptide prodrug derivatives of parent compounds, which are P-gp substrates. Therefore, the objective of this study is to functionally characterize the peptide mediated uptake and transport of [H-3] Glycylsarcosine ([H-3] Gly-Sar), a model peptide substrate across MDCKII-MDR1 cells. [H-3] Gly-Sar uptake from apical (AP) and basolateral (BL) membranes was found to be time-dependent and saturable. Michaelis-Menten (K-m) constants of [H-3] Gly-Sar uptake across the AP and BL directions in MDCKII-MDR1 cell line were found to be 457 +/- 37 and 464 +/- 85 mu M, respectively. V-max values in AP and BL directions for the peptide transporters in MDCKII-MDR1 cell line were calculated to be 0.035 +/- 0.001 and 0.35 +/- 0.034 pmol/min mg protein, respectively. Uptake of [H-3] Gly-Sar was significantly inhibited in the presence of aminocephalosporins and ACE-Inhibitors, known substrates for peptide transporters in both the AP and BL directions. Permeability of [H-3] Gly-Sar in the BL direction was maximal at pH 4 as compared to pH 5, 6 and 7.4 whereas such permeability in the AP direction was optimal at pH 7.4. Transepithelial transport of [H-3] Gly-Sar in the AP-BL direction was significantly lower than from BL-AP direction at all observed pHs. No statistical difference was observed in the transepithelial permeability of [H-3] Gly-Sar across both AP and BL directions over 4-10 days of growth period. The present study indicates that peptide transporters are effectively involved in the bidirectional transport of Gly-Sar across MDCKII-MDR1 cell line; the BL peptide transporter can transport Gly-Sar at a greater rate as compared to the AP peptide transporter. Results from these studies suggest the application of MDCKII-MDR1 cell line as a rapid effective tool to study peptide mediated influx of compounds that may be substrates for both P-gp and peptide transporters. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:147 / 152
页数:6
相关论文
共 20 条
[1]   THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCE [J].
ENDICOTT, JA ;
LING, V .
ANNUAL REVIEW OF BIOCHEMISTRY, 1989, 58 :137-171
[2]   BIOCHEMISTRY OF MULTIDRUG-RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER [J].
GOTTESMAN, MM ;
PASTAN, I .
ANNUAL REVIEW OF BIOCHEMISTRY, 1993, 62 :385-427
[3]   Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT) [J].
Guo, A ;
Marinaro, W ;
Hu, PD ;
Sinko, PJ .
DRUG METABOLISM AND DISPOSITION, 2002, 30 (04) :457-463
[4]   MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening [J].
Irvine, JD ;
Takahashi, L ;
Lockhart, K ;
Cheong, J ;
Tolan, JW ;
Selick, HE ;
Grove, JR .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 88 (01) :28-33
[5]   Effects of intestinal CYP3A4 and P-glycoprotein on oral drug absorption - Theoretical approach [J].
Ito, K ;
Kusuhara, H ;
Sugiyama, Y .
PHARMACEUTICAL RESEARCH, 1999, 16 (02) :225-231
[6]   Evasion of P-gp mediated cellular efflux and permeability enhancement of HIV-protease inhibitor saquinavir by prodrug modification [J].
Jain, R ;
Agarwal, S ;
Majumdar, S ;
Zhu, XD ;
Pal, D ;
Mitra, AK .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 303 (1-2) :8-19
[7]   Circumventing P-glycoprotein-mediated cellular efflux of quinidine by prodrug derivatization [J].
Jain, Ritesh ;
Majumdar, Sountyajit ;
Nashed, Yasser ;
Pal, Dhananjay ;
Mitra, Ashim K. .
MOLECULAR PHARMACEUTICS, 2004, 1 (04) :290-299
[8]   Development, validation and utility of an in vitro technique for assessment of potential clinical drug-drug interactions involving P-glycoprotein [J].
Keogh, JP ;
Kunta, JR .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 27 (05) :543-554
[9]   Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine [J].
Lown, KS ;
Mayo, RR ;
Leichtman, AB ;
Hsiao, HL ;
Turgeon, DK ;
SchmiedlinRen, P ;
Brown, MB ;
Guo, WS ;
Rossi, SJ ;
Benet, LZ ;
Watkins, PB .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 62 (03) :248-260
[10]   MDR- and CYMA4-mediated drug-herbal interactions [J].
Pal, D ;
Mitra, AK .
LIFE SCIENCES, 2006, 78 (18) :2131-2145